Etofylline

CAS No. 519-37-9

Etofylline( Etofylline | Oxyphylline | Dilaphyllin | Frekaphyllin | Soluphylline | Theophylline | BRN0251760 )

Catalog No. M14819 CAS No. 519-37-9

Etofylline is used as a Bronchodilator Agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 42 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG 38 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Etofylline
  • Note
    Research use only, not for human use.
  • Brief Description
    Etofylline is used as a Bronchodilator Agent.
  • Description
    Etofylline is used as a Bronchodilator Agent.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Etofylline | Oxyphylline | Dilaphyllin | Frekaphyllin | Soluphylline | Theophylline | BRN0251760
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    519-37-9
  • Formula Weight
    224.22
  • Molecular Formula
    C9H12N4O3
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in Water
  • SMILES
    O=C(N1C)N(C)C2=C(N(CCO)C=N2)C1=O
  • Chemical Name
    7-(2-hydroxyethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Nirogi RV, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Apr 1;848(2):271-6.
molnova catalog
related products
  • Dynamin inhibitory p...

    Control peptide version of dynamin inhibitory peptide, myristoylated, an inhibitor of the GTPase dynamin that competitively blocks binding of dynamin to amphiphysin, preventing endocytosis. In contrast to dynamin inhibitory peptide, has no significant effect on GABAA receptor-mediated miniature IPSPs.

  • UNC7467

    UNC7467 is a potent IP6K inhibitor with IC50 values of 4.9 nM for IP6K2, 8.9 nM for IP6K1, and 1320 nM for IP6K6.

  • (R)-Elagolix

    (R)-Elagolix is a short-acting, nonpeptide, GnRH antagonist with an IC50 and Ki of 0.25 and 3.7 nM, respectively.?